Oops, Qualigen Therapeutics Inc. Gets a Slap on the Wrist from NASDAQ for Late Form 10-K Filing
Qualigen Therapeutics, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing What Happened? Greetings, fellow life science enthusiasts! Have you heard the latest news from Qualigen Therapeutics, Inc.? It seems that on April 20, 2023, the company received a letter from the Nasdaq regarding a delayed Form 10-K filing. What does this mean for Qualigen…